Inflammatory Bowel Disease: Review
DOI:
https://doi.org/10.31533/pubvet.v15n12a977.1-10Keywords:
gastrointestinal tract, lymphoplasmacytic, gastroscopyAbstract
Inflammatory Bowel Disease (IBD) denotes a chronic illness of the gastrointestinal tract, characterized by persistent or recurrent clinical signs such as diarrhea, vomiting, loss of appetite and progressive weight loss. The IBD affects mainly middle aged dogs and cats, with no preference for gender. Although not having a clear etiology, most studies present it as a multifactorial disease, involving an exaggerated inflammatory immunological response against microbiota bacterias or antigens in dietary composition, with which the animal organism is not well adapted. The abnormal bacteria growth also seems to be related to IBD development. Specific dog breeds such as German Shepherd, West Highland White Terrier, Labrador, Basenji, Shar Pei and Poodle have a genetic predisposition to IBD, but it is not well elucidated. The diagnosis is established through the identification of the chronic gastrointestinal signs and the analysis both for image findings and biopsy histopathology. Some of the differential diagnosis of IBD includes giardiasis, linfoma, dietary hypersensitivity, E. coli infection and exocrine pancreatic insufficiency, that must be discarded with complementary exams. The treatment for IBD normally involves dietary changes and prescribed medications such as antibiotics and immunosuppressive drugs. The use of antibiotics is justified by the fact that bacterial antigens might be implicated in IBD etiology, but also because secondary bacterial development often occurs. Some authors argue the exclusive use of dietary therapy, because in some patients only this change can lead to parcial ou complete remission of the symptoms. There aren't studies about IBD prevention, because of its genetic etiology, but for the animal that has been already diagnosed with the disease there are some protocols to be followed, such as the use of hypoallergenic animal food, prebiotics, probiotics and synbiotics.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Maria Luiza Oliveira Marques, Letícia Duarte Fernandes, Natalie Taborda Simone, Caio da Silva Caldeira, William Alves Carneiro Junior
This work is licensed under a Creative Commons Attribution 4.0 International License.
Você tem o direito de:
Compartilhar — copiar e redistribuir o material em qualquer suporte ou formato
Adaptar — remixar, transformar, e criar a partir do material para qualquer fim, mesmo que comercial.
O licenciante não pode revogar estes direitos desde que você respeite os termos da licença. De acordo com os termos seguintes:
Atribuição
— Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso. Sem restrições adicionais
— Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.